GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials
Experience.
History-Making.
GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing
Revolutionizing IND Filings with Rapid Analytics: Streamlined Platform Strategies for Faster and Safer Biopharmaceutical Development
Scaling Strategies in Drug Product Process Development: From Laboratory to Commercial Production
Innovation in Bispecific and Multi-Specific Antibody Engineering
DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity
Exploring Key Trends at BioProcess International East: Enhancing Efficiency Across Bioprocessing Phases
Novel Conjugation approaches to developing RadioImmune Conjugates – Case Studies
Emerging Trends in Bioconjugation: What the Future Holds
How Can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
